{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T08:04:02Z","timestamp":1771661042296,"version":"3.50.1"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2021,6,7]],"date-time":"2021-06-07T00:00:00Z","timestamp":1623024000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,6,7]],"date-time":"2021-06-07T00:00:00Z","timestamp":1623024000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["2 T32 DK 7201-42"],"award-info":[{"award-number":["2 T32 DK 7201-42"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["K23DK11954201"],"award-info":[{"award-number":["K23DK11954201"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["P30 DK046200"],"award-info":[{"award-number":["P30 DK046200"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007265","name":"School of Medicine, Boston University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002558","name":"Warren Alpert Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100002558","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J GEN INTERN MED"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1007\/s11606-021-06931-1","type":"journal-article","created":{"date-parts":[[2021,6,7]],"date-time":"2021-06-07T17:03:31Z","timestamp":1623085411000},"page":"3487-3496","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Self-identified Race and COVID-19-Associated Acute Kidney Injury and Inflammation: a Retrospective Cohort Study of Hospitalized Inner-City COVID-19 Patients"],"prefix":"10.1007","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6501-6180","authenticated-orcid":false,"given":"Nipith","family":"Charoenngam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Titilayo O.","family":"Ilori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael F.","family":"Holick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natasha S.","family":"Hochberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline M.","family":"Apovian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,6,7]]},"reference":[{"key":"6931_CR1","first-page":"167","volume":"123","author":"WJ Riley","year":"2012","unstructured":"Riley WJ. Health disparities: gaps in access, quality and affordability of medical care. Trans Am Clin Climatol Assoc. 2012;123:167-74.","journal-title":"Trans Am Clin Climatol Assoc."},{"key":"6931_CR2","doi-asserted-by":"publisher","unstructured":"Price JH, Khubchandani J, McKinney M, Braun R. Racial\/ethnic disparities in chronic diseases of youths and access to health care in the United States. Biomed Res Int. 2013;2013:787616. doi:https:\/\/doi.org\/10.1155\/2013\/787616","DOI":"10.1155\/2013\/787616"},{"key":"6931_CR3","doi-asserted-by":"publisher","unstructured":"LaVeist TA, Gaskin D, Richard P. Estimating the Economic Burden of Racial Health Inequalities in the United States. International Journal of Health Services. 2011;41(2):231-8. doi:https:\/\/doi.org\/10.2190\/HS.41.2.c","DOI":"10.2190\/HS.41.2.c"},{"key":"6931_CR4","doi-asserted-by":"publisher","unstructured":"Qui\u00f1ones AR, Botoseneanu A, Markwardt S, Nagel CL, Newsom JT, Dorr DA, et al. Racial\/ethnic differences in multimorbidity development and chronic disease accumulation for middle-aged adults. PLoS One. 2019;14(6):e0218462-e. doi:https:\/\/doi.org\/10.1371\/journal.pone.0218462","DOI":"10.1371\/journal.pone.0218462"},{"key":"6931_CR5","doi-asserted-by":"publisher","unstructured":"Grams ME, Chow EKH, Segev DL, Coresh J. Lifetime incidence of CKD stages 3-5 in the United States. Am J Kidney Dis. 2013;62(2):245-52. doi:https:\/\/doi.org\/10.1053\/j.ajkd.2013.03.009","DOI":"10.1053\/j.ajkd.2013.03.009"},{"key":"6931_CR6","doi-asserted-by":"publisher","unstructured":"Beydoun MA, Beydoun HA, Mode N, Dore GA, Canas JA, Eid SM, et al. Racial disparities in adult all-cause and cause-specific mortality among us adults: mediating and moderating factors. BMC Public Health. 2016;16(1):1113. doi:https:\/\/doi.org\/10.1186\/s12889-016-3744-z","DOI":"10.1186\/s12889-016-3744-z"},{"key":"6931_CR7","doi-asserted-by":"publisher","unstructured":"Bryson CL, Ross HJ, Boyko EJ, Young BA. Racial and Ethnic Variations in Albuminuria in the US Third National Health and Nutrition Examination Survey (NHANES III) Population: Associations With Diabetes and Level of CKD. American Journal of Kidney Diseases. 2006;48(5):720-6. doi:https:\/\/doi.org\/10.1053\/j.ajkd.2006.07.023","DOI":"10.1053\/j.ajkd.2006.07.023"},{"key":"6931_CR8","doi-asserted-by":"publisher","unstructured":"Andermann A, Collaboration C. Taking action on the social determinants of health in clinical practice: a framework for health professionals. CMAJ. 2016;188(17-18):E474-E83. doi:https:\/\/doi.org\/10.1503\/cmaj.160177","DOI":"10.1503\/cmaj.160177"},{"key":"6931_CR9","doi-asserted-by":"publisher","unstructured":"Hu B, Guo H, Zhou P, Shi Z-L. Characteristics of SARS-CoV-2 and COVID-19. Nature Reviews Microbiology. 2020. doi:https:\/\/doi.org\/10.1038\/s41579-020-00459-7","DOI":"10.1038\/s41579-020-00459-7"},{"key":"6931_CR10","doi-asserted-by":"publisher","unstructured":"The Lancet Infectious D. COVID-19, a pandemic or not? Lancet Infect Dis. 2020;20(4):383. doi:https:\/\/doi.org\/10.1016\/S1473-3099(20)30180-8","DOI":"10.1016\/S1473-3099(20)30180-8"},{"key":"6931_CR11","doi-asserted-by":"publisher","unstructured":"Kullar R, Marcelin JR, Swartz TH, Piggott DA, Macias Gil R, Mathew TA, et al. Racial Disparity of Coronavirus Disease 2019 in African American Communities. J Infect Dis. 2020;222(6):890-3. doi:https:\/\/doi.org\/10.1093\/infdis\/jiaa372","DOI":"10.1093\/infdis\/jiaa372"},{"key":"6931_CR12","doi-asserted-by":"publisher","unstructured":"Williamson EJ, Walker AJ, Bhaskaran K, Bacon S, Bates C, Morton CE, et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature. 2020;584(7821):430-6. doi:https:\/\/doi.org\/10.1038\/s41586-020-2521-4","DOI":"10.1038\/s41586-020-2521-4"},{"key":"6931_CR13","unstructured":"Racial data transparency. Center JHUR. 2020. https:\/\/coronavirus.jhu.edu\/data\/racial-data-transparency. ."},{"key":"6931_CR14","unstructured":"COVID-19 Cases, Hospitalizations, and Deaths, by Race\/Ethnicity. Centers for Disease Control and Prevention. 2020. https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/downloads\/covid-data\/hospitalization-death-by-race-ethnicity.pdf. ."},{"key":"6931_CR15","doi-asserted-by":"publisher","unstructured":"Golestaneh L, Neugarten J, Fisher M, Billett HH, Gil MR, Johns T, et al. The association of race and COVID-19 mortality. EClinicalMedicine. 2020;25. doi:https:\/\/doi.org\/10.1016\/j.eclinm.2020.100455","DOI":"10.1016\/j.eclinm.2020.100455"},{"key":"6931_CR16","doi-asserted-by":"publisher","unstructured":"Louis-Jean J, Cenat K, Njoku CV, Angelo J, Sanon D. Coronavirus (COVID-19) and Racial Disparities: a Perspective Analysis. J Racial Ethn Health Disparities. 2020;7(6):1039-45. doi:https:\/\/doi.org\/10.1007\/s40615-020-00879-4","DOI":"10.1007\/s40615-020-00879-4"},{"key":"6931_CR17","doi-asserted-by":"publisher","unstructured":"Snowden LR, Graaf G. COVID-19, Social Determinants Past, Present, and Future, and African Americans' Health. J Racial Ethn Health Disparities. 2021;8(1):12-20. doi:https:\/\/doi.org\/10.1007\/s40615-020-00923-3","DOI":"10.1007\/s40615-020-00923-3"},{"key":"6931_CR18","doi-asserted-by":"publisher","unstructured":"Price-Haywood EG, Burton J, Fort D, Seoane L. Hospitalization and Mortality among Black Patients and White Patients with Covid-19. New England Journal of Medicine. 2020;382(26):2534-43. doi:https:\/\/doi.org\/10.1056\/NEJMsa2011686","DOI":"10.1056\/NEJMsa2011686"},{"key":"6931_CR19","doi-asserted-by":"publisher","unstructured":"Rentsch CT, Kidwai-Khan F, Tate JP, Park LS, King JT, Skanderson M, et al. Covid-19 by Race and Ethnicity: A National Cohort Study of 6 Million United States Veterans. medRxiv. 2020:2020.05.12.20099135. doi:https:\/\/doi.org\/10.1101\/2020.05.12.20099135","DOI":"10.1101\/2020.05.12.20099135"},{"key":"6931_CR20","unstructured":"https:\/\/www.incomebyzipcode.com\/massachusetts."},{"key":"6931_CR21","doi-asserted-by":"publisher","unstructured":"Komaromy M, Harris, Koenig MRM, Tomanovich MM, Ruiz-Mercado G, Barocas JA. Caring for COVID's most vulnerable victims: a safety-net hospital responds. Res Sq. 2020:rs.3.rs-97328. doi:https:\/\/doi.org\/10.21203\/rs.3.rs-97328\/v1","DOI":"10.21203\/rs.3.rs-97328\/v1"},{"key":"6931_CR22","doi-asserted-by":"publisher","unstructured":"Yan H, Valdes AM, Vijay A, Wang S, Liang L, Yang S, et al. Role of Drugs Used for Chronic Disease Management on Susceptibility and Severity of COVID-19: A Large Case-Control Study. Clinical Pharmacology & Therapeutics. 2020;108(6):1185-94. doi:https:\/\/doi.org\/10.1002\/cpt.2047","DOI":"10.1002\/cpt.2047"},{"key":"6931_CR23","doi-asserted-by":"publisher","unstructured":"Vila-C\u00f3rcoles A, Ochoa-Gondar O, Satu\u00e9-Gracia EM, Torrente-Fraga C, Gomez-Bertomeu F, Vila-Rovira A, et al. Influence of prior comorbidities and chronic medications use on the risk of COVID-19 in adults: a population-based cohort study in Tarragona, Spain. BMJ Open. 2020;10(12):e041577. doi:https:\/\/doi.org\/10.1136\/bmjopen-2020-041577","DOI":"10.1136\/bmjopen-2020-041577"},{"key":"6931_CR24","doi-asserted-by":"publisher","unstructured":"Fogarty H, Townsend L, Ni Cheallaigh C, Bergin C, Martin-Loeches I, Browne P, et al. COVID19 coagulopathy in Caucasian patients. British Journal of Haematology. 2020;189(6):1044-9. doi:https:\/\/doi.org\/10.1111\/bjh.16749","DOI":"10.1111\/bjh.16749"},{"key":"6931_CR25","doi-asserted-by":"publisher","unstructured":"Folsom AR, Basu S, Hong C-P, Heckbert SR, Lutsey PL, Rosamond WD, et al. Reasons for Differences in the Incidence of Venous Thromboembolism in Black Versus White Americans. Am J Med. 2019;132(8):970-6. doi:https:\/\/doi.org\/10.1016\/j.amjmed.2019.03.021","DOI":"10.1016\/j.amjmed.2019.03.021"},{"key":"6931_CR26","doi-asserted-by":"publisher","unstructured":"Zakai NA, McClure LA, Judd SE, Safford MM, Folsom AR, Lutsey PL, et al. Racial and regional differences in venous thromboembolism in the United States in 3 cohorts. Circulation. 2014;129(14):1502-9. doi:https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.113.006472","DOI":"10.1161\/CIRCULATIONAHA.113.006472"},{"key":"6931_CR27","doi-asserted-by":"publisher","unstructured":"Zakai N, Lutsey P, Folsom A, Cushman M. Black-White Differences In Venous Thrombosis Risk: the Longitudinal Investigation of Thromboembolism Etiology (LITE). Blood. 2010;116(21):478. doi:https:\/\/doi.org\/10.1182\/blood.V116.21.478.478","DOI":"10.1182\/blood.V116.21.478.478"},{"key":"6931_CR28","doi-asserted-by":"publisher","unstructured":"Lutsey PL, Cushman M, Steffen LM, Green D, Barr RG, Herrington D, et al. Plasma hemostatic factors and endothelial markers in four racial\/ethnic groups: the MESA study. Journal of Thrombosis and Haemostasis. 2006;4(12):2629-35. doihttps:\/\/doi.org\/10.1111\/j.1538-7836.2006.02237.x","DOI":"10.1111\/j.1538-7836.2006.02237.x"},{"key":"6931_CR29","doi-asserted-by":"publisher","unstructured":"Khaleghi M, Saleem U, McBane RD, Mosley TH, Jr., Kullo IJ. African-American ethnicity is associated with higher plasma levels of D-dimer in adults with hypertension. J Thromb Haemost. 2009;7(1):34-40. doi:https:\/\/doi.org\/10.1111\/j.1538-7836.2008.03215.x","DOI":"10.1111\/j.1538-7836.2008.03215.x"},{"key":"6931_CR30","doi-asserted-by":"publisher","unstructured":"O\u2019Bryan TA, Agan BK, Tracy RP, Freiberg MS, Okulicz JF, So-Armah K, et al. Brief Report: Racial Comparison of D-Dimer Levels in US Male Military Personnel Before and After HIV Infection and Viral Suppression. J Acquir Immune Defic Syndr. 2018;77(5):502-6. doi:https:\/\/doi.org\/10.1097\/QAI.0000000000001626","DOI":"10.1097\/QAI.0000000000001626"},{"key":"6931_CR31","doi-asserted-by":"publisher","unstructured":"Guan W-j, Ni Z-Y, Hu Y, Liang W-H, Ou C-Q, He J-X, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. New England Journal of Medicine. 2020;382(18):1708-20. doi:https:\/\/doi.org\/10.1056\/NEJMoa2002032","DOI":"10.1056\/NEJMoa2002032"},{"key":"6931_CR32","doi-asserted-by":"publisher","unstructured":"Cheng Y, Luo R, Wang K, Zhang M, Wang Z, Dong L, et al. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int. 2020;97(5):829-38. doi:https:\/\/doi.org\/10.1016\/j.kint.2020.03.005","DOI":"10.1016\/j.kint.2020.03.005"},{"key":"6931_CR33","doi-asserted-by":"publisher","unstructured":"Zahid U, Ramachandran P, Spitalewitz S, Alasadi L, Chakraborti A, Azhar M, et al. Acute Kidney Injury in COVID-19 Patients: An Inner City Hospital Experience and Policy Implications. Am J Nephrol. 2020;51(10):786-96. doi:https:\/\/doi.org\/10.1159\/000511160","DOI":"10.1159\/000511160"},{"key":"6931_CR34","doi-asserted-by":"publisher","unstructured":"Mohamed MMB, Lukitsch I, Torres-Ortiz AE, Walker JB, Varghese V, Hernandez-Arroyo CF, et al. Acute Kidney Injury Associated with Coronavirus Disease 2019 in Urban New Orleans. Kidney360. 2020;1(7):614. doi:https:\/\/doi.org\/10.34067\/KID.0002652020","DOI":"10.34067\/KID.0002652020"},{"key":"6931_CR35","doi-asserted-by":"publisher","unstructured":"Yang X, Yu Y, Xu J, Shu H, Xia JA, Liu H, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. The Lancet Respiratory Medicine. 2020;8(5):475-81. doi:https:\/\/doi.org\/10.1016\/S2213-2600(20)30079-5","DOI":"10.1016\/S2213-2600(20)30079-5"},{"key":"6931_CR36","doi-asserted-by":"publisher","unstructured":"Nimkar A, Naaraayan A, Hasan A, Pant S, Durdevic M, Suarez CN, et al. Incidence and Risk Factors for Acute Kidney Injury and Its Effect on Mortality in Patients Hospitalized From COVID-19. Mayo Clinic Proceedings: Innovations, Quality & Outcomes. 2020;4(6):687-95. doi:https:\/\/doi.org\/10.1016\/j.mayocpiqo.2020.07.003","DOI":"10.1016\/j.mayocpiqo.2020.07.003"},{"key":"6931_CR37","doi-asserted-by":"publisher","unstructured":"Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet. 2020;395(10223):497-506. doi:https:\/\/doi.org\/10.1016\/S0140-6736(20)30183-5","DOI":"10.1016\/S0140-6736(20)30183-5"},{"key":"6931_CR38","doi-asserted-by":"publisher","unstructured":"Bansal M. Cardiovascular disease and COVID-19. Diabetes Metab Syndr. 2020;14(3):247-50. doi:https:\/\/doi.org\/10.1016\/j.dsx.2020.03.013","DOI":"10.1016\/j.dsx.2020.03.013"},{"key":"6931_CR39","doi-asserted-by":"publisher","unstructured":"Martinez-Rojas MA, Vega-Vega O, Bobadilla NA. Is the kidney a target of SARS-CoV-2? Am J Physiol Renal Physiol. 2020;318(6):F1454-F62. doi:https:\/\/doi.org\/10.1152\/ajprenal.00160.2020","DOI":"10.1152\/ajprenal.00160.2020"},{"key":"6931_CR40","doi-asserted-by":"publisher","unstructured":"Taxbro K, Kahlow H, Wulcan H, Fornarve A. Rhabdomyolysis and acute kidney injury in severe COVID-19 infection. BMJ Case Rep. 2020;13(9):e237616. doi:https:\/\/doi.org\/10.1136\/bcr-2020-237616","DOI":"10.1136\/bcr-2020-237616"},{"key":"6931_CR41","doi-asserted-by":"publisher","unstructured":"Ronco C, Reis T. Kidney involvement in COVID-19 and rationale for extracorporeal therapies. Nat Rev Nephrol. 2020;16(6):308-10. doi:https:\/\/doi.org\/10.1038\/s41581-020-0284-7","DOI":"10.1038\/s41581-020-0284-7"},{"key":"6931_CR42","doi-asserted-by":"publisher","unstructured":"Hirsch JS, Ng JH, Ross DW, Sharma P, Shah HH, Barnett RL, et al. Acute kidney injury in patients hospitalized with COVID-19. Kidney Int. 2020;98(1):209-18. doi:https:\/\/doi.org\/10.1016\/j.kint.2020.05.006","DOI":"10.1016\/j.kint.2020.05.006"},{"key":"6931_CR43","doi-asserted-by":"publisher","unstructured":"Bowe B, Cai M, Xie Y, Gibson AK, Maddukuri G, Al-Aly Z. Acute Kidney Injury in a National Cohort of Hospitalized US Veterans with COVID-19. Clinical Journal of the American Society of Nephrology. 2020:CJN.09610620. doi:https:\/\/doi.org\/10.2215\/CJN.09610620","DOI":"10.2215\/CJN.09610620"},{"key":"6931_CR44","doi-asserted-by":"publisher","unstructured":"Grams ME, Matsushita K, Sang Y, Estrella MM, Foster MC, Tin A, et al. Explaining the racial difference in AKI incidence. J Am Soc Nephrol. 2014;25(8):1834-41. doi:https:\/\/doi.org\/10.1681\/ASN.2013080867","DOI":"10.1681\/ASN.2013080867"},{"key":"6931_CR45","doi-asserted-by":"publisher","unstructured":"Phillips N, Park I-W, Robinson JR, Jones HP. The Perfect Storm: COVID-19 Health Disparities in US Blacks. J Racial Ethn Health Disparities. 2020:1-8. doi:https:\/\/doi.org\/10.1007\/s40615-020-00871-y","DOI":"10.1007\/s40615-020-00871-y"},{"key":"6931_CR46","doi-asserted-by":"publisher","unstructured":"Calcagnile M, Forgez P, Iannelli A, Bucci C, Alifano M, Alifano P. ACE2 polymorphisms and individual susceptibility to SARS-CoV-2 infection: insights from an <em>in silico<\/em> study. bioRxiv. 2020:2020.04.23.057042. doi:https:\/\/doi.org\/10.1101\/2020.04.23.057042","DOI":"10.1101\/2020.04.23.057042"},{"key":"6931_CR47","doi-asserted-by":"publisher","unstructured":"Slopen N, Lewis TT, Gruenewald TL, Mujahid MS, Ryff CD, Albert MA, et al. Early life adversity and inflammation in African Americans and whites in the midlife in the United States survey. Psychosom Med. 2010;72(7):694-701. doi:https:\/\/doi.org\/10.1097\/PSY.0b013e3181e9c16f","DOI":"10.1097\/PSY.0b013e3181e9c16f"},{"key":"6931_CR48","doi-asserted-by":"publisher","unstructured":"Vinciguerra M, Greco E. Sars-CoV-2 and black population: ACE2 as shield or blade? Infect Genet Evol. 2020;84:104361. doi:https:\/\/doi.org\/10.1016\/j.meegid.2020.104361","DOI":"10.1016\/j.meegid.2020.104361"},{"key":"6931_CR49","doi-asserted-by":"publisher","unstructured":"Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357(3):266-81. doi:https:\/\/doi.org\/10.1056\/NEJMra070553","DOI":"10.1056\/NEJMra070553"},{"key":"6931_CR50","doi-asserted-by":"publisher","unstructured":"Kumar R, Rathi H, Haq A, Wimalawansa SJ, Sharma A. Putative roles of vitamin D in modulating immune response and immunopathology associated with COVID-19. Virus Res. 2021;292:198235. doi:https:\/\/doi.org\/10.1016\/j.virusres.2020.198235","DOI":"10.1016\/j.virusres.2020.198235"},{"key":"6931_CR51","doi-asserted-by":"publisher","unstructured":"Charoenngam N, Holick MF. Immunologic Effects of Vitamin D on Human Health and Disease. Nutrients. 2020;12(7):2097. doi:https:\/\/doi.org\/10.3390\/nu12072097","DOI":"10.3390\/nu12072097"},{"key":"6931_CR52","doi-asserted-by":"publisher","unstructured":"Charoenngam N, Shirvani A, Holick MF. Vitamin D and Its Potential Benefit for the COVID-19 Pandemic. Endocr Pract. 2021:S1530-891X(21)00087-2. doi:https:\/\/doi.org\/10.1016\/j.eprac.2021.03.006","DOI":"10.1016\/j.eprac.2021.03.006"},{"key":"6931_CR53","doi-asserted-by":"publisher","unstructured":"Velez JCQ, Caza T, Larsen CP. COVAN is the new HIVAN: the re-emergence of collapsing glomerulopathy with COVID-19. Nature Reviews Nephrology. 2020;16(10):565-7. doi:https:\/\/doi.org\/10.1038\/s41581-020-0332-3","DOI":"10.1038\/s41581-020-0332-3"},{"key":"6931_CR54","doi-asserted-by":"publisher","unstructured":"Kopp JB, Smith MW, Nelson GW, Johnson RC, Freedman BI, Bowden DW, et al. MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis. Nat Genet. 2008;40(10):1175-84. doi:https:\/\/doi.org\/10.1038\/ng.226","DOI":"10.1038\/ng.226"},{"key":"6931_CR55","doi-asserted-by":"publisher","unstructured":"Nichols B, Jog P, Lee JH, Blackler D, Wilmot M, D'Agati V, et al. Innate immunity pathways regulate the nephropathy gene Apolipoprotein L1. Kidney Int. 2015;87(2):332-42. doi:https:\/\/doi.org\/10.1038\/ki.2014.270","DOI":"10.1038\/ki.2014.270"},{"key":"6931_CR56","doi-asserted-by":"publisher","unstructured":"Wu H, Larsen CP, Hernandez-Arroyo CF, Mohamed MMB, Caza T, Sharshir MD, et al. AKI and Collapsing Glomerulopathy Associated with COVID-19 and <em>APOL<\/em><span class=&quot;sc&quot;><em>1<\/em><\/span> High-Risk Genotype. Journal of the American Society of Nephrology. 2020;31(8):1688. doi:https:\/\/doi.org\/10.1681\/ASN.2020050558","DOI":"10.1681\/ASN.2020050558"},{"key":"6931_CR57","doi-asserted-by":"publisher","unstructured":"Graham G. Disparities in cardiovascular disease risk in the United States. Curr Cardiol Rev. 2015;11(3):238-45. doi:https:\/\/doi.org\/10.2174\/1573403\u00d711666141122220003","DOI":"10.2174\/1573403\u00d711666141122220003"},{"key":"6931_CR58","doi-asserted-by":"publisher","unstructured":"Laster M, Shen JI, Norris KC. Kidney Disease Among African Americans: A Population Perspective. Am J Kidney Dis. 2018;72(5 Suppl 1):S3-S7. doi:https:\/\/doi.org\/10.1053\/j.ajkd.2018.06.021","DOI":"10.1053\/j.ajkd.2018.06.021"},{"key":"6931_CR59","doi-asserted-by":"publisher","unstructured":"Kim EJ, Kim T, Conigliaro J, Liebschutz JM, Paasche-Orlow MK, Hanchate AD. Racial and Ethnic Disparities in Diagnosis of Chronic Medical Conditions in the USA. J Gen Intern Med. 2018;33(7):1116-23. doi:https:\/\/doi.org\/10.1007\/s11606-018-4471-1","DOI":"10.1007\/s11606-018-4471-1"},{"key":"6931_CR60","doi-asserted-by":"publisher","unstructured":"Beigel JH, Tomashek KM, Dodd LE, Mehta AK, Zingman BS, Kalil AC, et al. Remdesivir for the Treatment of Covid-19 - Final Report. The New England journal of medicine. 2020;383(19):1813-26. doi:https:\/\/doi.org\/10.1056\/NEJMoa2007764","DOI":"10.1056\/NEJMoa2007764"},{"key":"6931_CR61","doi-asserted-by":"publisher","unstructured":"Ahmed MH, Hassan A. Dexamethasone for the Treatment of Coronavirus Disease (COVID-19): a Review. SN Compr Clin Med. 2020:1-10. doi:https:\/\/doi.org\/10.1007\/s42399-020-00610-8","DOI":"10.1007\/s42399-020-00610-8"},{"key":"6931_CR62","doi-asserted-by":"crossref","unstructured":"Feiner JR, Severinghaus JW, Bickler PE. Dark Skin Decreases the Accuracy of Pulse Oximeters at Low Oxygen Saturation: The Effects of Oximeter Probe Type and Gender. Anesthesia & Analgesia. 2007;105(6).","DOI":"10.1213\/01.ane.0000285988.35174.d9"}],"container-title":["Journal of General Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-021-06931-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11606-021-06931-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-021-06931-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,7]],"date-time":"2022-06-07T00:05:40Z","timestamp":1654560340000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11606-021-06931-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,7]]},"references-count":62,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["6931"],"URL":"https:\/\/doi.org\/10.1007\/s11606-021-06931-1","relation":{},"ISSN":["0884-8734","1525-1497"],"issn-type":[{"value":"0884-8734","type":"print"},{"value":"1525-1497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,7]]},"assertion":[{"value":"1 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Michael F. Holick is a former consultant for Quest Diagnostics Inc., a consultant for Biogena Inc. and Ontometrics Inc., and on the speaker\u2019s Bureau for Abbott Inc. Caroline M. Apovian reports receiving personal fees from Nutrisystem, Zafgen, Sanofi-Aventis, Orexigen, EnteroMedics, GI Dynamics, Scientific Intake, Gelesis, Novo Nordisk, SetPoint Health, Xeno Biosciences, Rhythm Pharmaceuticals, Eisai, and Takeda outside of the funded work; reports receiving grant funding from Aspire Bariatrics, GI Dynamics, Orexigen, Takeda, the Vela Foundation, Gelesis, Energesis, Coherence Lab, and Novo Nordisk outside of the funded work; and reports past equity interest in ScienceSmart, LLC.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}